Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology, Trends in Manufacturing, May 2022
Volume2022 eBook
Issue 2
Pages: 58-59

Embracing New Realities

Author(s):

Virtual and augmented reality have emerged as critical digital training tools.

andrush - adobe.stock.com

andrush - adobe.stock.com

While a conclusive ‘end’ to the pandemic remains elusive, the transition to a post-pandemic economic model has been defined by a mass ramp-up of various means of digital communication. Digital training tools are one such solution, often allowing companies to effectively prepare employees for the job before they even set foot on-site. While these tools can take on many forms, of particular prominence are augmented reality (AR) and virtual reality (VR) visualization technologies.

Read this article in Pharmaceutical Technology's Trends in Manufacturing eBook.

About the authors

Grant Playter is the Assistant Editor at Pharmaceutical Technology.

Article details

Pharmaceutical Technology
eBook: Trends in Manufacturing
May 2022
Pages: 58–59

Citation

When referring to this article, please cite it as G. Playter, "Embracing New Realities," Pharmaceutical Technology's Trends in Manufacturing eBook (May 2022).

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content